Neurol. praxi. 2016;17(3):134 | DOI: 10.36290/neu.2016.041

The heidenhain variant of sporadic Creutzfeldt-Jakob disease

MUDr. Lenka Hönigová, MUDr. Jiří Neumann
Neurologické oddělení, Krajská zdravotní a.s. &ndash, Nemocnice Chomutov

Prion diseases are rare neurodegenerative conditions with a lethal course. These diseases are caused by deposition in the brain of a pathologically altered prion protein, leading to gradual neuronal degeneration and irreversible brain damage. Creutzfeldt-Jakob disease (CJD) is the best-known and most common human prion disease. It is clinically manifested by a wide range of symptoms, rapid progression, and poor prognosis. Early-onset rapidly progressive dementia is typical. We report a case of a 49-year-old man with presumed sporadic CJD that was confirmed by neuropathological investigation. It was shown to be a rare Heidenhain variant dominated by disorders of visual-spatial functions in the prodromal phase. In the Czech Republic, the diagnosis of CJD and other prion diseases is dealt with by the National Reference Laboratory for Human Prion Diseases.

Keywords: prion diseases, Creutzfeldt-Jakob disease, Heidenhain variant

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hönigová L, Neumann J. The heidenhain variant of sporadic Creutzfeldt-Jakob disease. Neurol. praxi. 2016;17(3):134. doi: 10.36290/neu.2016.041.
Download citation

References

  1. Cooper SA, Murray KL, Heath CA, Will RG, Knight RSG. Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the "Heidenhain variant". Br J Ophthlamol 2005; 89: 1341-1342. Go to original source... Go to PubMed...
  2. Cummings JL. Creutzfeldt-Jakob diseases and other prion disorders. In: Cummings JL. The neuropsychiatry of Alzheimer's disease and related dementias. London: Martin Dunitz Ltd, 2003: 243-253. Go to original source...
  3. Franková V, Krauzová M. Lidské prionové nemoci. Psychiatr. praxi, 2008; 9(3): 116-119.
  4. Gdovinová Z. Creutzfeldtova-Jakobova nemoc. Cesk Slov Neurol N 2013; 76(2): 138-154.
  5. Jacobs DA, Lesser RL, Mourelatos Z, Galetta SL, Balcer LJ. The Heidenhain variant of Creutzfeldt-Jakob disease: clinical, pathologic, and neuroimaging findings. J Neuroophthalmol. 2001; 21: 99-102. Go to original source... Go to PubMed...
  6. Kalp M, Gottschalk CHH. Mystery Case: Heidenhain variant of Creutzfeldt-Jakob disease. Neurology 2014; 83: e187. Go to original source... Go to PubMed...
  7. Kropp SF, Schulz-Schaeffer WJ, Finkenstaedt M, Riedemann Ch, Windl O, Steinhoff BJ, Zerr I, Kretzschmar HA, Poser S. The Heidenhain Variant of Creutzfeldt-Jakob disease. Arch Neurol 1999; 56(1): 55-61. Go to original source... Go to PubMed...
  8. Kümpel P, Thomasová E. Výskyt sporadické Creutzfeldt-Jakobovy nemoci s typickým průběhem u romské ženy. Neurol. praxi 2007; 3: 153-154.
  9. Ling H, Sullivan SS, Holton JL, Revesz T, Massey LK, Williams DR, Paviour DC, Lees AJ. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 2010; 133(7): 2045-2057. Go to original source... Go to PubMed...
  10. Mastrianni JA, Roos RP. The prion diseases. Semin Neurol 2000; 20(3): 337-352. Go to original source... Go to PubMed...
  11. Matěj R, Nováková J, Fiala J, Koukolík F, Rusina R. Vyšetřování proteinu 14-3-3 v mozkomíšním moku - klinicko-patologická korelace. Cesk Slov Neurol N. 2008; 104(71): 695-699.
  12. Meyer A, Leigh D, Bagg CE. A rare presenile dementia associated with cortical blindness (Heidenhain's syndrome). J Neurol Neurosurg Psychiatry 1954; 17-129-133. Go to original source... Go to PubMed...
  13. Mitrová E. Contribution of CSF biomarkers to the early diagnosis of human genetic transmissible spongiform encephalopathies. ENJ 2012; 4(1): 9-14.
  14. Mitrová E. Prionové choroby a ich akutálny epidemiologický význam. Neurol. praxi 2007; 3: 143-144.
  15. Okáčová I, Bednařík J, Mitášová A, Košťálová M, Skutilová S, Balabánová P. Heidenhainova varianta Creutzfeldt-Jakobovy nemoci - kazuistika. Neurol. praxi 2011; 12(Suppl. C): 21-22.
  16. Prusiner SB. The prion disease. Brain Pathol 1998; 8(3): 499-513. Go to original source...
  17. Rusina R, Matěj R. Prionová onemocnění. Neurol. praxi 2012; 13(2): 78-82.
  18. Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer WJ, Poser S, Kretzschmar HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 2004; 56(5): 702-708. Go to original source... Go to PubMed...
  19. Tanwani LK, Furman CD, Ritchie CS. Diagnostic challanges in Creutzfeldt-Jakob disease: Case report. South Med J 2003; 96(8): 832-835. Go to original source... Go to PubMed...
  20. Verma R, Junewar V, Sahu R. Creutzfeldt-Jakob disease presenting with visual symptoms: a case of the "Heidenhain variant". BMJ Case Reports 2013 (2013): bcr2012008006 Go to original source...
  21. Vojtěch Z, Procházka T, Marečková I. Elektroencefalografie v neurointenzivní péči. Neurol. praxi 2007; 1: 17-23.
  22. Young GS, Geswind MD, Fischbein NJ, Martindale JL, Henry RG, Liu S, Lu Y, Wong S, Liu H, Miller BL, Dillon WP. Diffusion weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease high sensitivity and specifity for diagnosis. AJNR Am J Neuroradiol 2005; 26: 1551-1562.
  23. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heineman U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Coliie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132(Pt10): 2659-2668. Go to original source... Go to PubMed...
  24. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Laupetre N, Cauddrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55(6): 811-815. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.